These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 23081833)

  • 1. Equine cellular therapy--from stall to bench to bedside?
    Burk J; Badylak SF; Kelly J; Brehm W
    Cytometry A; 2013 Jan; 83(1):103-13. PubMed ID: 23081833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The regenerative medicine laboratory: facilitating stem cell therapy for equine disease.
    Borjesson DL; Peroni JF
    Clin Lab Med; 2011 Mar; 31(1):109-23. PubMed ID: 21295725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Extracorporal shock wave therapy in veterinary medicine].
    Schnewlin M; Lischer C
    Schweiz Arch Tierheilkd; 2001 May; 143(5):227-32. PubMed ID: 11407246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equine embryonic stem-like cells and mesenchymal stromal cells have different survival rates and migration patterns following their injection into damaged superficial digital flexor tendon.
    Guest DJ; Smith MR; Allen WR
    Equine Vet J; 2010 Oct; 42(7):636-42. PubMed ID: 20840579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-based therapies: current issues and future directions.
    Stewart MC
    Vet Clin North Am Equine Pract; 2011 Aug; 27(2):393-9. PubMed ID: 21872767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal shock wave therapy for treatment of osteoarthritis in the horse: clinical applications.
    Revenaugh MS
    Vet Clin North Am Equine Pract; 2005 Dec; 21(3):609-25, vi. PubMed ID: 16297724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Customer service in equine veterinary medicine.
    Blach EL
    Vet Clin North Am Equine Pract; 2009 Dec; 25(3):421-32. PubMed ID: 19945637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and future regenerative medicine - principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine.
    Koch TG; Berg LC; Betts DH
    Can Vet J; 2009 Feb; 50(2):155-65. PubMed ID: 19412395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical update on the use of mesenchymal stem cells in equine orthopaedics.
    Frisbie DD; Smith RK
    Equine Vet J; 2010 Jan; 42(1):86-9. PubMed ID: 20121921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease.
    Sánchez L; Gutierrez-Aranda I; Ligero G; Rubio R; Muñoz-López M; García-Pérez JL; Ramos V; Real PJ; Bueno C; Rodríguez R; Delgado M; Menendez P
    Stem Cells; 2011 Feb; 29(2):251-62. PubMed ID: 21732483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future directions in treatment of joint disease in horses.
    Frisbie DD
    Vet Clin North Am Equine Pract; 2005 Dec; 21(3):713-24, viii. PubMed ID: 16297729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equine embryos and embryonic stem cells: defining reliable markers of pluripotency.
    Paris DB; Stout TA
    Theriogenology; 2010 Sep; 74(4):516-24. PubMed ID: 20071015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of stemness in equine mesenchymal stem cells: a plea for uniformity.
    De Schauwer C; Meyer E; Van de Walle GR; Van Soom A
    Theriogenology; 2011 May; 75(8):1431-43. PubMed ID: 21196039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current 'state of play' of regenerative medicine in horses: what the horse can tell the human.
    Smith RK; Garvican ER; Fortier LA
    Regen Med; 2014; 9(5):673-85. PubMed ID: 25372081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Veterinary science and the Internet: tangible help for a better understanding of equine atypical myopathy.
    Harris P
    Vet J; 2009 Apr; 180(1):1-2. PubMed ID: 18674938
    [No Abstract]   [Full Text] [Related]  

  • 16. Human placental stem cells: biomedical potential and clinical relevance.
    Malek A; Bersinger NA
    J Stem Cells; 2011; 6(2):75-92. PubMed ID: 22997848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cells in veterinary medicine--attempts at regenerating equine tendon after injury.
    Richardson LE; Dudhia J; Clegg PD; Smith R
    Trends Biotechnol; 2007 Sep; 25(9):409-16. PubMed ID: 17692415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equine peripheral blood-derived progenitors in comparison to bone marrow-derived mesenchymal stem cells.
    Koerner J; Nesic D; Romero JD; Brehm W; Mainil-Varlet P; Grogan SP
    Stem Cells; 2006 Jun; 24(6):1613-9. PubMed ID: 16769763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cell therapy for equine tendinopathy.
    Smith RK
    Disabil Rehabil; 2008; 30(20-22):1752-8. PubMed ID: 18608378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic use of stem cells in horses: which type, how, and when?
    Schnabel LV; Fortier LA; McIlwraith CW; Nobert KM
    Vet J; 2013 Sep; 197(3):570-7. PubMed ID: 23778257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.